Tidlig seponering af svigtende behandling anbefales for at begrænse akkumulering af multiple mutationer, som kan være ugunstig for en efterfølgende supplerende behandling.
Early discontinuation of failing therapies is recommended in order to limit the accumulation of multiple mutations, which may be detrimental to a subsequent rescue regimen.